Cellular and molecular aspects of glucuronidation proceedings of the International Congress on Cellular and Molecular Aspects of Glucuronidation, held in Montpellier, France, 27-29, April 1988 = Aspects cellulaires et moléculaires de la glucuronoconjugaison by International Congress on Cellular and Molecular Aspects of Glucuronidation (5th 1988 Montpellier, France)

Cover of: Cellular and molecular aspects of glucuronidation | International Congress on Cellular and Molecular Aspects of Glucuronidation (5th 1988 Montpellier, France)

Published by INSERM in Paris .

Written in English

Read online

Subjects:

  • Biotransformation (Metabolism) -- Congresses.

Edition Notes

Includes bibliographical references and index.

Book details

Other titlesAspects cellulaires et moléculaires de la glucuronoconjugaison.
Statementsponsored by the Institut national de la santé et de la recherche médicale (INSERM) ; edited by Gérard Siest, Jacques Magdalou, Brian Burchell.
SeriesColloques INSERM,, v. 173, Colloques de l"Institut national de la santé et de la recherche médicale ;, no 173.
ContributionsBurchell, Brian., Magdalou, Jacques., Siest, G., Institut national de la santé et de la recherche médicale (France)
Classifications
LC ClassificationsMLCM 92/12056 (Q)
The Physical Object
Paginationxx, 327 p. :
Number of Pages327
ID Numbers
Open LibraryOL2262187M
ISBN 102855983533, 086196182X
LC Control Number89144662
OCLC/WorldCa20303268

Download Cellular and molecular aspects of glucuronidation

Cellular and molecular aspects of glucuronidation = Aspects cellulaires et moléculaires de la glucuronoconjugaison. proceedings of the International congress on cellular and molecular aspects of glucuronidation, held in Montpellier, France, April ; ed.

by Gérard Siest, Jacques Magdalou, Brian Burchell. http:\/\/at. Get this from a library. Cellular and molecular aspects of glucuronidation: proceedings of the International Congress on Cellular and Molecular Aspects of Glucuronidation, held in Montpellier, France,April = Aspects cellulaires et moléculaires de la glucuronoconjugaison.

[Brian Burchell; Jacques Magdalou; G Siest; Institut national de la santé et de la recherche médicale. The conjugation of xenobiotic molecules with hydrophilic molecular species such as glucuronic acid is known as phase II metabolism.

Sites Edit Glucuronidation occurs mainly in the liver, although the enzyme responsible for its catalysis, UDP-glucuronyltransferase, has been found in all major body organs (e.g., intestine, kidneys, brain.

Human Drug Metabolism, 3rd Edition is an excellent book for advanced undergraduate and graduate students in molecular biology, biochemistry, pharmacology, pharmacy, and toxicology. It will also appeal to professionals interested in an introduction to this field, or who want to learn more about these bench-to-bedside topics to apply it to their Author: Michael D.

Coleman. Glucuronidation is a major pathway of xenobiotic biotransformation in most mammalian species, and requires the cofactor uridine diphosphate-glucuronic acid. 68, The reaction is metabolized by UGTs (also called glucuronyltransferases), which are present in many tissues. 68, The site of glucuronidation is generally an electron-rich.

Glucuronidation. Glucuronidation is an important phase II reaction catalyzed by the UDP-glucuronosyltransferases (UGTs), UGTs are enzymes involved in a number of metabolic processes, including phase II drug metabolism (35% of therapeutic drugs undergo conjugation with glucuronic acid prior to elimination); From: Molecular Diagnostics, 1.

Author(s): Siest,G; Magdalou,Jacques; Burchell,Brian; International Congress on Cellular and Molecular Aspects of Glucuronidation,(5th: Montpellier, France); Institut national de la santé et de la recherche médicale (France) Title(s): Cellular and molecular aspects of glucuronidation: Cellular and molecular aspects of glucuronidation book of the International Congress on Cellular and Molecular Aspects.

Psychology Definition of GLUCURONIDATION: Name of the metabolic process where drugs and other substances are combined with glucuronic acid to. Transcripts of the UGT1A gene, encoding half of human UDP-glucuronosyltransferase (UGT) enzymes, undergo alternative splicing, resulting in active enzymes named isoforms 1 (i1s) and novel truncated isoforms 2 (i2s).

Here, we investigated the effects of depleting endogenous i2 on drug response and attempted to unveil any additional biologic Cited by: II. N-Glucuronidation of Heterocyclic Amines. Besides the pyridine derivatives, a marked number of aromatic diaza- and polyazaheterocyclic compounds are known to undergo N-glucuronidation.

Model imidazole, triazole, tetrazoles yield tertiary N-glucuronides. Steric hindrance a major determinant of Size: 3MB.

Cellular and molecular aspects of glucuronidation book Drug Metabolism, An Introduction, Second Edition provides an accessible introduction to the subject and will be particularly invaluable to those who already have some understanding of the life sciences.

Completely revised and updated throughout, the new edition focuses only on essential chemical detail and includes patient case histories to illustrate the Author: Michael D. Coleman. Positive regulation of cellular glucuronidation Antibodies.

Antibodies for proteins involved in positive regulation of cellular glucuronidation pathways; according to their Panther/Gene Ontology Classification. a leading global provider of molecular. This can lead to activation of immune responses, which could further aggravate cellular damage.

The interplay between xenobiotic-induced molecular changes, organelle dysfunction and activation of immunity results in cell death and liver injury. Cellular ATP availability is an important determinant of the type of cell death that occurs.

Cite this chapter as: Burchell B. () Molecular Cloning, Expression and Genetic Deficiencies Of UDP-Glucuronosyltransferases.

In: Arinç E., Schenkman J.B., Hodgson E. (eds) Molecular Aspects of Monooxygenases and Bioactivation of Toxic : Brian Burchell. The importance of the thyroid hormone axis in the regulation of skeletal growth and maintenance has been well established from clinical studies Cited by: Glucuronidation reaction is catalyzed by mammalian uridine diphosphoglucuronosyl transferases by using uridine diphosphoglucuronic acid as a cosubstrate.

Conjugation of glucuronic acid to nucleophilic functional groups in chemical entities results in formation of glucuronides. As anticipated, a number of nucleophilic functional groups such as hydroxyl, phenolic, acyl.

Glucuronidation of amines has been shown to exhibit species differences in vitro and in vivo. Substrates for N -glucuronidation can be classified according to the chemical structures of the resulting glucuronides into two groups: compounds that form non-quaternary N -conjugates, and those that form the quaternary counterparts.

For compounds of the former Cited by: UDP-glucuronosyltransferase is an enzyme that in humans is encoded by the UGT1A6 gene.

Function. UDP-glucuronosyltransferase is a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites.

This gene is part of a Aliases: UGT1A6, GNT1, HLUGP, HLUGP1. Start studying Glucuronidation, Sulphation and Other Phase 2 Reactions. Learn vocabulary, terms, and more with flashcards, games, and other study tools.

These results establish LW-1 as a glucuronide, now named glucuronidine, and for the first time raise the possible existence of a “glucuronidation pathway of diabetic complications”. Future research is needed to rigorously probe this concept and elucidate the molecular origin and biological source of a circulating glucuronidine by: 1.

∙Vd is determined by molecular size, lipid solubility, acid/base properties and binding to circulating and tissue proteins ∙The Vd does not necessarily refer to any real volume → it is the size of a compartment necessary to account for the total drug in the body IF it were present throughout the body in the same concentration found in the.

Chapter 3 - Glucuronidation in humans: Pharmacogenetic and developmental aspects 22 Beaulieu M, Levesque E, Tchernof A, Beatty B, Belanger A, Hum D. Chromosomal localization, structure, and regulation. Dual Roles for Splice Variants of the Glucuronidation Pathway as Regulators of Cellular Metabolism Article (PDF Available) in Molecular pharmacology 85(1).

Drug metabolism is the metabolic breakdown of drugs by living organisms, usually through specialized enzymatic systems. More generally, xenobiotic metabolism (from the Greek xenos "stranger" and biotic "related to living beings") is the set of metabolic pathways that modify the chemical structure of xenobiotics, which are compounds foreign to an organism's normal.

Glucuronidation is the major pathway in phase II metabolism and accounts for approximately 35% of drug conjugation. UGTs are microsomal membrane-bound and catalyze the transfer of a glucuronate group of uridine diphosphoglucuronate (UDPGA, a co-substrate) to the functional group of specific substrates.

GL-V9 is a prominent derivative of wogonin with a wide therapeutic spectrum and potent anti-tumor activity. The metabolism characteristics of GL-V9 remain unclear. This study aimed to clarify the metabolic pathway of GL-V9 and investigate the generation of its glucuronidation metabolites in vitro and in vivo.

HPLC-UV-TripleTOF was used to identify metabolites. The Cited by: 1. The nature and functional group of a drug molecule will determine which one of these processes be in favour e.g. acetaminophen undergoes both glucuronidation and sulfation, however at high doses glucuronidation predominates and at low doses sulfation predominate (Airpine &.

Glucuronide formation can be a major avenue of drug metabolism. O-Glucuronidation enhances the bile/plasma ratio of a metabolite relative to the parent drug. However, glucuronides are more polar and ionic than the parent drug, and while most glucuronides are inactive, they are not always lower in toxicity or inactivation.

-glucuronidation and the importance of. in vitro. studies utilizing human-derived material, along with animal studies, at the early stages of drug development.

Furthermore, this study highlights the contribution of UGT2B10, along with UGT1A4, to the. N-glucuronidation of drugs and other xenobiotics in the human liver. Glucuronidation sites are nucleophilic heteroatoms rich in electrons (like O, N or S).

Thus, in glucuronidation reaction mostly involved substrates comprise of functional groups, like phenols and aliphatic alcohols. So, in human body metabolism glucuronidation is main binding reaction of phenolic compounds.

Steffen et al. reported the Cited by: 2. Glucuronidation is a phase II biotransformation reaction in which glucuronide acts as a conjugation molecule and binds to a substrate via the catalysis of glucuronosyltransferases.

First, in a series of reactions the cosubstrate uridine diphosphate glucuronic acid (UDPGA) is formed. Bioavailability of Polyphenols and Flavonoids in the Era of Precision MedicineCited by: Estrogen, or oestrogen, is the primary female sex is responsible for the development and regulation of the female reproductive system and secondary sex are three major endogenous estrogens in females that have estrogenic hormonal activity: estrone, estradiol, and estrane steroid estradiol is the most potent and prevalent of code: G03C.

Definition of glucuronidation in the dictionary. Meaning of glucuronidation. What does glucuronidation mean. Information and translations of glucuronidation in the most comprehensive dictionary definitions resource on the web. Oxidative stress has been considered a key causing factor of liver damage induced by a variety of agents, including alcohol, drugs, viral infections, environmental pollutants and dietary components, which in turn results in progression of liver injury, non-alcoholic steatohepatitis, non-alcoholic liver disease, liver fibrosis and cirrhosis.

During the past 30 years and even after the Cited by: Interindividual variability in human drug glucuronidation What we know and what we need to know Laboratory of Comparative and Molecular Pharmacogenomics Department of Pharmacology and Experimental Therapeutics.

Tufts University School of Medicine. Michael H Court, BVSc, PhD. Benet LZ, Spahn H “Acyl migration and covalent binding of drug glucuronides — potential toxicity mediators” In: Siest G, Magdalou J, Burchell B (eds) “Molecular and Cellular Aspects of Glucuronidation”, Colloques INSERM/John Libbey Eurotext, Vol.London, ().

Google Scholar. This special issue of Molecular Pharmaceutics, “Transport−Metabolism Interplay”, highlights these various approaches.

The review by Benet describes the progress made in uncovering and understanding the interplay between CYP3A and P-gp as well as uptake transporters through in vitro, animal and human by: 7.

Midazolam is a short-acting benzodiazepine derivative with an imidazole structure and with anxiolytic, amnestic, hypnotic, anticonvulsant and sedative properties. Midazolam exerts its effect by binding to the benzodiazepine receptor at the gamma-aminobutyric acid receptor-chloride ionophore complex in the central nervous system (CNS).

This leads to an increase in the. Disclaimer. Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations.

In-depth coverage of advances in molecular biology, indicating the importance of drug and xenobiotic conjugates as transport forms of biologically active compounds. Part One describes molecular events associated with the expression and regulation of transferases and hydrolases involved in Phase II drug conjugation and deconjugation.The glucuronidation reaction consists of the transfer of the glucuronosyl group from uridine 5'-diphospho-glucuronic acid (UDPGA) to substrate molecules that contain oxygen, nitrogen, sulfur or carboxyl functional groups.

The resulting glucuronide is more polar (e.g. hydrophilic) and more easily excreted than the substrate : BRENDA entry.title = "Structure-metabolism relationships in the glucuronidation of d-amino acid oxidase inhibitors", abstract = "Representative d-amino acid oxidase (DAAO) inhibitors were subjected to in vitro liver microsomal stability tests in the absence or presence of uridine diphosphate glucuronic acid (UDPGA).Cited by: 4.

49953 views Monday, November 9, 2020